Molecules for the millennium: how will they look? New drug discovery year 2000

por Sausville, E A, Johnson, J I
Publicado 2000

P21-dependent G (1) arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228

por Sandor, V, Senderowicz, A, Mertins, S, Sackett, D, Sausville, E, Blagosklonny, M V, Bates, S E
Publicado 2000

In vitro evaluation of amino acid prodrugs of novel antitumour 2-(4-amino-3-methylphenyl)benzothiazoles

por Bradshaw, T D, Chua, M-S, Browne, H L, Trapani, V, Sausville, E A, Stevens, M F G
Publicado 2002

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

por Johnson, J I, Decker, S, Zaharevitz, D, Rubinstein, L V, Venditti, J M, Schepartz, S, Kalyandrug, S, Christian, M, Arbuck, S, Hollingshead, M, Sausville, E A
Publicado 2001

DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells

por Trapani, V, Patel, V, Leong, C-O, Ciolino, H P, Yeh, G C, Hose, C, Trepel, J B, Stevens, M F G, Sausville, E A, Loaiza-Pérez, A I
Publicado 2003